Technical Analysis for TVTX - Travere Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Up 5 Days in a Row | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 1.04% | |
| New Uptrend | Bullish | 1.04% | |
| Wide Range Bar | Range Expansion | 1.04% | |
| Weak + Overbought | Other | 1.04% | |
| Wide Bands | Range Expansion | 1.04% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| Down 3% | about 17 hours ago |
| Rose Above Upper Bollinger Band | about 21 hours ago |
| Up 2% | about 21 hours ago |
| Upper Bollinger Band Resistance | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.5424 |
| 52 Week Low | 5.12 |
| Average Volume | 1,271,100 |
| 200-Day Moving Average | 9.03 |
| 50-Day Moving Average | 6.99 |
| 20-Day Moving Average | 6.01 |
| 10-Day Moving Average | 6.02 |
| Average True Range | 0.45 |
| RSI (14) | 59.35 |
| ADX | 35.11 |
| +DI | 31.87 |
| -DI | 20.60 |
| Chandelier Exit (Long, 3 ATRs) | 6.34 |
| Chandelier Exit (Short, 3 ATRs) | 6.47 |
| Upper Bollinger Bands | 6.94 |
| Lower Bollinger Band | 5.08 |
| Percent B (%b) | 0.93 |
| BandWidth | 30.88 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.34 |
| MACD Histogram | 0.203 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.49 | ||||
| Resistance 3 (R3) | 7.45 | 7.19 | 7.38 | ||
| Resistance 2 (R2) | 7.19 | 7.02 | 7.21 | 7.34 | |
| Resistance 1 (R1) | 7.01 | 6.92 | 7.10 | 7.04 | 7.30 |
| Pivot Point | 6.75 | 6.75 | 6.80 | 6.77 | 6.75 |
| Support 1 (S1) | 6.56 | 6.58 | 6.66 | 6.60 | 6.34 |
| Support 2 (S2) | 6.30 | 6.47 | 6.32 | 6.30 | |
| Support 3 (S3) | 6.12 | 6.30 | 6.26 | ||
| Support 4 (S4) | 6.15 |
